Can an injection restore hearing? new trial tests DX243 in older adults
NCT ID NCT07637981
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests an investigational drug called DX243 in people with mild to moderate age-related hearing loss. Participants receive daily injections of DX243 or a placebo for 29 days. The study checks whether the drug is safe and whether it improves hearing, using speech-in-noise tests and questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DX243
What this could lead to
If effective, DX243 could offer a new treatment to improve hearing in older adults with mild to moderate hearing loss.
What could go wrong
This is an early-phase trial with only 24 participants, so results may not apply broadly. Safety and efficacy are still unproven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED HEARING LOSS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Predicting Age-Related Hearing Loss – NCT07612618
- Age-Related Hearing Loss & Dementia Study | NCT07608640
- rTMS & Hearing Aids for Cognitive Decline in Hea NCT07389213
- Liuwei Dihuang Pill for Age-Related Hearing Loss NCT05125081
- Understanding Speech in Noise with Hearing Aids NCT06377215
- Hearing Aid Optimization Study | NCT06420037
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre hospitalier Universitaire de Liège Sart Tilman
RECRUITINGLiège, Liège, 4000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••